All In Biotech

Free tool

FAERS Monitor: Doptelet Sprinkle

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 219696 or its brand name (Doptelet Sprinkle, Avatrombopag Maleate). Reports on generic versions are filed under their own applications.

Reports

375

Serious

340

91% of reports

Hospitalization

145

Death reported

49

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use67
  • drug ineffective46
  • platelet count decreased34
  • therapy non-responder26
  • immune thrombocytopenia23
  • thrombocytopenia19
  • death16
  • infection16
  • diarrhoea15
  • pneumonia15
  • abdominal pain14
  • myelofibrosis14
  • platelet count abnormal14
  • pulmonary embolism14
  • neutrophil count decreased13

Reports by year received

View as table
YearReports
20131
20182
20191
20204
202113
202233
202357
202491
2025102
202671

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,784 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
immune thrombocytopeniaSignal23283.2190.46,158
myelofibrosisSignal14260.9155.83,354
platelet count abnormalSignal14130.277.81,665
therapy non-responderSignal2632.522.4763
platelet count decreasedSignal3417.913.0528
neutrophil count decreasedSignal1317.910.5191
thrombocytopeniaSignal199.56.1137
pulmonary embolismSignal148.34.983
infectionSignal166.23.865
off label useSignal674.33.5173
abdominal painSignal143.42.021
pneumoniaSignal152.61.613
drug ineffective462.01.522
diarrhoea151.30.81
death161.00.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.